GlassScriptPhysician profile
Rajesh Khanna
NPI 1104854249
$3,609.45
in general payments reported to CMS, 2019-2025
22 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.38 · 2020: $189 · 2021: $282 · 2022: $284 · 2023: $1,047 · 2024: $588 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,637 · Long Term Medical Supply Or Device Loan: $85.28 · Gift: $36.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,636.71 |
| Long Term Medical Supply Or Device Loan | $85.28 |
| Gift | $36.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $697.15 | 2025 | Lensar Laser System |
| Glaukos Corporation | $612.06 | 2020-2025 | Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| Bausch & Lomb Americas INC. | $451.63 | 2022-2023 | Infuse, Btod, Xiidra |
| Johnson & Johnson Surgical Vision, INC. | $231.25 | 2019-2024 | Lipiflow System Activator (Disposable), Catalys System |
| Tarsus Pharmaceuticals, INC. | $229.09 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $223.83 | 2023-2025 | Acuvue |
| Carl Zeiss Meditec USA, INC. | $179.82 | 2022-2025 | Iolmaster 700, Visumax |
| Novartis Pharmaceuticals Corporation | $176.87 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $167.35 | 2020-2025 | Cequa |
| Rxsight INC | $160.34 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Sight Sciences, INC. | $115.23 | 2020-2021 | |
| Abbvie INC. | $83.72 | 2023-2024 | |
| Oyster Point Pharma, INC. | $49.60 | 2023 | Tyrvaya |
| Carl Zeiss Meditec, INC. | $43.63 | 2019 | |
| New World Medical,INC. | $36.25 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $34.80 | 2023 | Oxervate |
| Beaver-Visitec International, INC. | $28.38 | 2025 | |
| Alcon Vision LLC | $24.33 | 2023 | Dailies Total1 |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Kala Pharmaceuticals, INC. | $17.79 | 2021 | |
| Philips North America LLC | $14.19 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajesh Khanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.